Related Experiment Video
Updated: Jul 24, 2026
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Valvular heart disease in pregnancy
Benjamin M Scirica1, Patrick T O'Gara
1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02461, USA.
Current Cardiology Reports
|March 10, 2006
Summary
Pregnant women with valvular heart disease need careful management. While most tolerate pregnancy, some conditions require intensive care or termination, balancing anticoagulation risks for mother and fetus.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Pregnancy induces physiological changes that can worsen pre-existing valvular heart disease.
- Management of valvular conditions during pregnancy may necessitate cardiovascular medications for fluid overload or arrhythmias.
- Certain valvular heart diseases pose significant risks during pregnancy, potentially requiring intensive management or pregnancy termination.
Purpose of the Study:
- To outline the evaluation and management strategies for pregnant women with valvular heart disease.
- To discuss the physiological adaptations during pregnancy that affect valvular function.
- To review anticoagulation considerations for pregnant women with valvular disease and prosthetic valves.
Main Methods:
- Review of current literature and clinical guidelines on managing valvular heart disease in pregnancy.
- Analysis of physiological changes during pregnancy and their impact on cardiac hemodynamics.
- Evaluation of risks and benefits of anticoagulation therapies in pregnant patients.
Main Results:
- Most pregnant women with valvular disease can be managed successfully, but some conditions are associated with higher risks.
- Cardiovascular medications may be required to manage pregnancy-induced complications like fluid overload and arrhythmias.
- Anticoagulation decisions for women with prosthetic valves or thromboembolism risk require a careful balance of maternal and fetal safety.
Conclusions:
- Careful preconception counseling and ongoing monitoring are crucial for pregnant women with valvular heart disease.
- Individualized management plans are essential, considering the specific valvular condition and physiological changes of pregnancy.
- Optimizing anticoagulation strategies is critical to prevent maternal thrombosis while minimizing fetal harm.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...